SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 68 filers reported holding SAVARA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,000 | -70.0% | 1,388 | -81.4% | 0.00% | – |
Q4 2020 | $10,000 | +400.0% | 7,481 | +234.7% | 0.00% | – |
Q3 2020 | $2,000 | -98.3% | 2,235 | -95.8% | 0.00% | – |
Q2 2020 | $118,000 | +25.5% | 53,711 | +7.4% | 0.00% | – |
Q1 2020 | $94,000 | +394.7% | 50,000 | +1059.8% | 0.00% | – |
Q4 2019 | $19,000 | +72.7% | 4,311 | +1.5% | 0.00% | – |
Q3 2019 | $11,000 | +83.3% | 4,248 | +60.4% | 0.00% | – |
Q2 2019 | $6,000 | +100.0% | 2,648 | +511.5% | 0.00% | – |
Q4 2018 | $3,000 | +50.0% | 433 | +116.5% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 200 | +12.4% | 0.00% | – |
Q2 2018 | $2,000 | -97.1% | 178 | -97.7% | 0.00% | – |
Q1 2018 | $70,000 | -38.6% | 7,622 | 0.0% | 0.00% | – |
Q4 2017 | $114,000 | – | 7,622 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
Woodline Partners LP | 374,904 | $431,000 | 0.01% |
Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |